CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
000078 Shenzhen Neptunus Bioengineering
- 2.27
- +0.02+0.89%
Market Closed Apr 30 15:00 CST
5.97BMarket Cap-4.92P/E (TTM)
2.30High2.24Low136.30KlotVolume2.24Open2.25Pre Close31.01MTurnover0.52%Turnover RatioLossP/E (Static)2.63BShares3.1952wk High3.29P/B5.96BFloat Cap2.0752wk Low2.48Limit Up2.63BShs Float14.30Historical High2.03Limit Down2.67%Amplitude0.40Historical Low--Dividend TTM2.27Avg Price60.78KlotAsk--Div YieldTTM100Lot Size72.73KlotBid
Shenzhen Neptunus Bioengineering Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -8.81%7.38B | -16.75%30.32B | -14.27%24.55B | -16.65%16.63B | -18.78%8.09B | -3.74%36.42B | -1.09%28.64B | 10.11%19.95B | 8.22%9.96B | -7.84%37.83B |
| Operating revenue | -8.81%7.38B | -16.75%30.32B | -14.27%24.55B | -16.65%16.63B | -18.78%8.09B | -3.74%36.42B | -1.09%28.64B | 10.11%19.95B | 8.22%9.96B | -7.84%37.83B |
| Other operating revenue | ---- | -5.37%102.93M | ---- | -17.38%70.98M | ---- | 42.96%108.77M | ---- | -5.42%85.91M | ---- | -40.20%76.08M |
| Total operating cost | -7.87%7.35B | -16.09%30.63B | -13.99%24.38B | -16.39%16.47B | -18.77%7.98B | -3.38%36.5B | -1.07%28.34B | 10.06%19.7B | 8.28%9.83B | -6.31%37.78B |
| Operating cost | -7.60%6.69B | -16.49%27.44B | -13.87%22.12B | -16.26%14.96B | -18.53%7.25B | -3.46%32.87B | -1.17%25.68B | 10.98%17.86B | 9.34%8.89B | -7.12%34.05B |
| Operating tax surcharges | -16.75%19.09M | -8.32%98.12M | -9.19%70.57M | -8.61%47.49M | -13.70%22.93M | 3.13%107.02M | 2.13%77.71M | 1.15%51.97M | -3.72%26.57M | -10.63%103.78M |
| Operating expense | -6.29%264.5M | -14.43%1.19B | -20.02%852.77M | -24.92%567.28M | -32.77%282.24M | -8.41%1.39B | -8.67%1.07B | 2.90%755.56M | 10.16%419.81M | -0.92%1.52B |
| Administration expense | -11.66%213.27M | -8.38%1.05B | -14.05%762.84M | -15.17%508.14M | -17.78%241.42M | -1.07%1.15B | -2.51%887.49M | -6.77%599.01M | -7.90%293.63M | -1.29%1.16B |
| Financial expense | -16.20%150.32M | -14.55%806.28M | -8.98%534.94M | -9.69%366.77M | -0.88%179.37M | 4.24%943.62M | 25.81%587.74M | 16.79%406.12M | -10.20%180.95M | 12.14%905.21M |
| -Interest expense (Financial expense) | -28.45%147.12M | -14.50%808.77M | -12.76%549.29M | -12.77%375.5M | -11.54%205.62M | 1.62%945.94M | 22.71%629.65M | 15.07%430.47M | -7.03%232.45M | 6.32%930.86M |
| -Interest Income (Financial expense) | 74.16%-7.13M | 8.61%-44.59M | 29.84%-47.67M | 30.97%-29.24M | 15.65%-27.57M | 25.48%-48.79M | -19.15%-67.94M | -6.86%-42.35M | 17.53%-32.68M | 30.51%-65.47M |
| Research and development | 11.14%11.25M | -20.80%37.97M | -13.41%32.13M | -6.41%21.53M | -10.73%10.12M | -1.02%47.94M | -1.49%37.11M | -10.84%23M | -1.77%11.34M | 23.47%48.43M |
| Credit Impairment Loss | -331.15%-36.31M | 30.73%-293.12M | 518.96%48.54M | 256.99%34.19M | 528.06%15.71M | -26.92%-423.17M | 39.49%-11.59M | -819.37%-21.78M | 16.85%-3.67M | -315.32%-333.42M |
| Asset Impairment Loss | 210.29%2.97M | 46.10%-518.75M | 132.25%941.22K | 5,584.83%6.42M | -63.27%956.1K | -74.84%-962.35M | 1.88%-2.92M | 91.57%-117.1K | 168.85%2.6M | -178.66%-550.41M |
| Other net revenue | 341.66%66.66M | 45.75%-750.17M | 206.80%89.5M | 210.50%52.09M | -56.34%15.09M | -52.46%-1.38B | -28.73%29.17M | -57.20%16.78M | 348.89%34.57M | -448.96%-906.99M |
| Fair value change income | -79.53%23.75K | -64.04%6.38M | 3,447.94%10.03M | -40.29%254.34K | --115.98K | -68.77%17.75M | 103.48%282.61K | 113.86%425.93K | ---- | 50.76%56.85M |
| Invest income | 1,290.07%95.3M | 124.54%11.15M | -118.22%-4.71M | -138.82%-9.47M | -130.40%-8.01M | 68.35%-45.42M | 69.05%25.83M | 74.85%24.39M | 304.05%26.34M | -484.44%-143.5M |
| -Including: Investment income associates | -82.49%9.15K | 115.99%4.32M | -99.31%12.86K | -85.86%124.12K | -97.75%52.27K | 74.75%-27M | --1.86M | --878K | -58.56%2.33M | -329.07%-106.92M |
| Asset deal income | -100.31%-1.85K | 110.28%6.81M | 195.72%5.83M | 902.45%5.46M | 228.77%602.91K | -71.42%3.24M | -82.29%1.97M | 137.31%544.97K | 686.58%183.38K | 4,970.57%11.33M |
| Other revenue | -18.09%4.68M | 37.71%37.36M | 85.11%28.87M | 14.38%15.22M | -37.25%5.72M | -47.99%27.13M | -65.16%15.6M | -56.02%13.31M | -3.16%9.11M | 39.77%52.16M |
| Operating profit | -26.66%89.3M | 27.59%-1.06B | -18.94%266.99M | -21.23%213.78M | -26.96%121.76M | -71.78%-1.47B | -5.95%329.38M | 3.31%271.4M | 23.25%166.7M | -252.33%-854.59M |
| Add:Non operating Income | 71.16%3.07M | 1.36%25.37M | -37.30%12.14M | -45.00%7.18M | -62.61%1.79M | -18.92%25.03M | 252.95%19.37M | 136.04%13.06M | 11.76%4.8M | -34.69%30.87M |
| Less:Non operating expense | -15.47%1.62M | 185.22%44.12M | 51.00%10.26M | 32.72%5.92M | -14.69%1.92M | -47.45%15.47M | -67.53%6.79M | -58.54%4.46M | -49.57%2.25M | -7.91%29.44M |
| Total profit | -25.39%90.76M | 25.83%-1.08B | -21.37%268.88M | -23.20%215.04M | -28.13%121.64M | -70.95%-1.46B | 2.14%341.96M | 8.75%280M | 25.28%169.25M | -248.04%-853.16M |
| Less:Income tax cost | -27.95%37.8M | -67.14%85.62M | -8.28%143.03M | -14.02%99.76M | -11.08%52.47M | 88.41%260.56M | 33.70%155.95M | 50.05%116.02M | 71.64%59M | -56.57%138.29M |
| Net profit | -23.44%52.96M | 32.09%-1.17B | -32.34%125.85M | -29.70%115.28M | -37.26%69.17M | -73.39%-1.72B | -14.74%186.01M | -8.98%163.98M | 9.46%110.25M | -484.48%-991.45M |
| Net profit from continuing operation | -23.44%52.96M | 32.09%-1.17B | -32.34%125.85M | -29.70%115.28M | -37.26%69.17M | -73.39%-1.72B | -14.74%186.01M | -8.98%163.98M | 9.46%110.25M | -484.48%-991.45M |
| Less:Minority Profit | 10.21%29.24M | 189.74%26.1M | -18.35%79.63M | -8.42%69.87M | -25.73%26.53M | -181.89%-29.09M | 13.08%97.53M | 14.89%76.3M | 19.90%35.72M | -78.42%35.52M |
| Net profit of parent company owners | -44.38%23.72M | 29.38%-1.19B | -47.77%46.22M | -48.21%45.41M | -42.79%42.64M | -64.56%-1.69B | -32.92%88.48M | -22.92%87.68M | 5.08%74.53M | -1,200.77%-1.03B |
| Earning per share | ||||||||||
| Basic earning per share | -44.44%0.009 | 29.38%-0.4536 | -45.34%0.0176 | -45.77%0.0173 | -40.22%0.0162 | -64.48%-0.6423 | -32.92%0.0322 | -22.95%0.0319 | 0.74%0.0271 | -1,200.00%-0.3905 |
| Diluted earning per share | -44.44%0.009 | 29.38%-0.4536 | -45.34%0.0176 | -45.77%0.0173 | -40.22%0.0162 | -64.48%-0.6423 | -32.92%0.0322 | -22.95%0.0319 | 0.74%0.0271 | -1,200.00%-0.3905 |
| Other composite income | -34.83%-23.5M | -790K | -790K | -106.95%-17.43M | -54.21%-8.42M | |||||
| Other composite income of parent company owners | ---- | -34.83%-23.5M | ---790K | ---790K | ---- | -106.95%-17.43M | ---- | ---- | ---- | -54.21%-8.42M |
| Total composite income | -23.44%52.96M | 31.42%-1.19B | -32.77%125.06M | -30.18%114.49M | -37.26%69.17M | -73.67%-1.74B | -14.74%186.01M | -8.98%163.98M | 9.46%110.25M | -496.14%-999.87M |
| Total composite income of parent company owners | -44.38%23.72M | 28.73%-1.22B | -48.66%45.43M | -49.11%44.62M | -42.79%42.64M | -64.90%-1.71B | -32.92%88.48M | -22.92%87.68M | 5.08%74.53M | -1,278.81%-1.04B |
| Total composite income of minority owners | 10.21%29.24M | 189.74%26.1M | -18.35%79.63M | -8.42%69.87M | -25.73%26.53M | -181.89%-29.09M | 13.08%97.53M | 14.89%76.3M | 19.90%35.72M | -78.42%35.52M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion with explanatory notes | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.